Effect of antibiotic sequence on combination regimens against Pseudomonas aeruginosa in a multiple-dose, in vitro...

Area of Science:

• Pharmacology
• Microbiology
• Infectious Diseases

Background:

• Pseudomonas aeruginosa is a significant opportunistic pathogen.
• Antibiotic combinations are crucial for treating resistant infections.
• The sequence of antibiotic administration can impact efficacy.

Purpose of the Study:

• To evaluate the impact of antibiotic sequence on combination therapy efficacy.
• To compare simultaneous versus staggered dosing of ceftazidime with ciprofloxacin or tobramycin.
• To assess the antibacterial activity against Pseudomonas aeruginosa in an in vitro model.

Main Methods:

• In vitro infection model using Pseudomonas aeruginosa.
• Combination regimens: ceftazidime plus ciprofloxacin, and ceftazidime plus tobramycin.
• Dosing schedules: simultaneous and staggered administration every 12 hours for 48 hours.

Main Results:

• Simultaneous dosing and early ceftazidime administration demonstrated significantly greater activity at 24h (p=0.03) and 48h (p<0.0001).
• Bacterial kill was sixfold greater with regimens where ceftazidime was administered first or simultaneously.
• Antibiotic sequence showed a significant and class-dependent effect on antibacterial response.

Conclusions:

• Antibiotic sequence critically influences the efficacy of combination therapy against Pseudomonas aeruginosa.
• Optimal sequencing involves simultaneous or early administration of ceftazidime.
• Further in vivo studies are warranted to confirm clinical relevance.